HIND

Vyome Holdings, Inc. operates as a specialty pharmaceutical company focused on dermatology and women's health. Headquartered in Mahwah, New Jersey, the company develops, manufactures, and commercializes prescription topical products for various skin conditions and therapeutic areas. Vyome's portfolio includes treatments for acne, rosacea, psoriasis, and other dermatological disorders, alongside products addressing women's health needs. The company markets its products primarily through dermatologists, gynecologists, and other healthcare providers across the United States. Vyome's business model centers on acquiring, developing, and commercializing specialty pharmaceutical assets with established clinical profiles, then optimizing their market performance through focused sales strategies. The company operates manufacturing facilities that support its vertical integration strategy, allowing greater control over product quality and supply chain management. In recent years, Vyome has pursued strategic acquisitions to expand its dermatology product portfolio and strengthen its market presence in the specialty pharmaceutical sector. The company competes in a fragmented dermatology market alongside both large pharmaceutical companies and smaller specialty firms, differentiating itself through its focused therapeutic approach and direct physician engagement model. Vyome employs approximately 200 professionals across its commercial, manufacturing, and research operations, supporting its product development pipeline and existing commercial portfolio.